Cardinal Health, Inc. (CAH) News
Follow Cardinal Health, Inc. (CAH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 32 public stories across 13 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Cardinal Health Raises Full-Year Earnings Outlook After Strong Q1
Cardinal Health shares posted a new record as the company raised its full-year earnings outlook following strong first-quarter results. Edwards Lifesciences shares also reached a more-than-three-year high amid bullish an
EQUITY | Nov 05, 2026, 06:07 PM UTC
M
Becton Dickinson and Cardinal Health Beat Quarterly Views
Becton Dickinson and Cardinal Health reported quarterly results that beat views.
EARNINGS | Nov 05, 2026, 06:04 PM UTC
M
Cardinal Health Reports Q1 Fiscal 2027 Results, Raises Outlook
Cardinal Health reported revenue of $67.513 billion, up from $64.009 billion a year earlier. Adjusted earnings were $3.26 per share, and the company raised its fiscal 2027 adjusted earnings outlook to $12.80–$13.00 per s
EQUITY | Nov 05, 2026, 01:03 PM UTC
M
Cardinal Health raises FY26 adjusted EPS outlook to $12.80–$13.00
The company lifted its prior full-year 2026 adjusted EPS forecast of $12.40 to…
EARNINGS | Nov 05, 2026, 12:17 PM UTC
M
Cardinal Health reports first-quarter EPS of $2.38
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Cardinal Health Reports Fiscal Q1 2027 Results, Raises Outlook
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Cardinal Health Q1 Adjusted EPS $3.26 vs. IBES Estimate $2.94
EARNINGS | Nov 05, 2026, 11:52 AM UTC
M
Cardinal Health Sees FY Adjusted EPS of $12.80–$13.00
EARNINGS | Nov 05, 2026, 11:51 AM UTC
M
Cardinal Health says Q1 results reflect a strong start to fiscal 2027
EQUITY | Nov 05, 2026, 11:49 AM UTC
M
Cardinal Health Reports 1Q Revenue of $67.5B
EARNINGS | Nov 05, 2026, 11:47 AM UTC
M
Cardinal Health Q1 revenue reaches USD 67,500 million
Cardinal Health reported Q1 revenue of USD 67,500 million, compared with the IBES estimate of USD 66,588 million.
EQUITY | Nov 05, 2026, 11:46 AM UTC
M
Cardinal Health Reports Q1 Net Income of $554 Million
EARNINGS | Nov 05, 2026, 11:46 AM UTC
M
Cardinal Health Reports First-Quarter Net Income of $554 Million
EARNINGS | Nov 05, 2026, 11:45 AM UTC
M
Cardinal Health Analysts Raise Price Targets Ahead of Earnings
Several analysts raised their price targets for Cardinal Health in recent weeks. The company is scheduled to report quarterly earnings Thursday; analysts expect EPS of $2.94 and revenue of $66.51 billion.
EQUITY | Nov 05, 2026, 08:21 AM UTC
M
Cardinal Health Q1'27 earnings preview
Cardinal Health is scheduled to report Q1'27 results on November 5 before the market opens, with disclosure expected at 6:45 a.m. ET (11:45 a.m. UTC).
EQUITY | Nov 04, 2026, 12:01 PM UTC
L
Sanofi settles U.S. antitrust lawsuit over Lantus
Sanofi settled a U.S. antitrust lawsuit concerning competition for its diabetes drug Lantus.
REGULATION | Oct 28, 2026, 08:42 PM UTC
M
Pentagon Awards Cardinal Health $1.5 Billion Contract
Cardinal Health secured a government contract under the Defense Department’s Medical Surgical Prime Vendor program. The fixed-price, indefinite-delivery/indefinite-quantity award followed a competitive bidding process.
EQUITY | Oct 27, 2026, 11:18 PM UTC
H
Cardinal Health, McKesson Double Down on CVS Deals Through 2032
Cardinal Health Inc. (NYSE: CAH ) on Thursday entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health Inc. (NYSE: CVS ) through June 30, 2032. Distribution Partnership With C
LIVE | Oct 01, 2026, 03:59 PM UTC
H
Cardinal Health shares are trading higher after the company reaffirmed its FY27 adjusted EPS guidance above estimates.
Cardinal Health shares are trading higher after the company reaffirmed its FY27 adjusted EPS guidance above estimates.
LIVE | Oct 01, 2026, 02:05 PM UTC
H
Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032
Cardinal Health (NYSE: CAH ) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardina
LIVE | Oct 01, 2026, 11:00 AM UTC
M
Cardinal Health to announce first-quarter fiscal 2027 results Nov. 5
Cardinal Health said it will announce first-quarter results for fiscal year 2027 on November 5.
EQUITY | Oct 01, 2026, 10:45 AM UTC
H
CAH: Double-digit growth across all segments, robust specialty gains, and strong cash flow progress
All five segments delivered strong double-digit earnings growth, with specialty and pharma outperforming expectations. Strategic acquisitions and operational improvements are driving sustainable growth, while contract st
EARNINGS | Sep 15, 2026, 02:34 PM UTC
H
CAH: Strong segment growth, robust cash flow, and strategic M&A drive continued performance
All five segments posted strong earnings growth, with specialty and M&A as key drivers, though future growth is expected to normalize. Strategic execution, stable customer renewals, and a focus on automation and targeted
EARNINGS | Sep 15, 2026, 01:59 PM UTC
H
CAH: Specialty and generics growth, strategic M&A, and disciplined investment drive strong outlook
Strong FY 2026 results were driven by specialty and generics, with FY 2027 guidance above long-term targets. Growth is supported by acquisitions, robust specialty and nuclear businesses, and disciplined capital allocatio
EARNINGS | Sep 09, 2026, 02:23 PM UTC
H
CAH sees FY 2027 EPS growth guidance of 13%-15%
CAH reported strong FY 2026 results tied to specialty and generics growth and guided FY 2027 EPS growth of 13%-15%. The company cited acquisition integration, cost management and targeted M&A.
EARNINGS | Sep 09, 2026, 01:43 PM UTC
M
Near 50dma resistance TIGO FICO LEN AFRM ESS DOC CXT FIS EXEL AN CNC CZR COST USB STZ BPOP BRKB CTVA ORCL DD TSLA PB MTB KR CL EWBC MCD AMG
Near 50dma resistance TIGO FICO LEN AFRM ESS DOC CXT FIS EXEL AN CNC CZR COST USB STZ BPOP BRKB CTVA ORCL DD TSLA PB MTB KR CL EWBC MCD AMG RF MLI PFG CASY OTIS FCN TPL CAH SFM SBAC NVR
EQUITY | Aug 21, 2026, 06:36 PM UTC
H
Cardinal Health gets RBC Buy, $276 target on Nuclear Medicine
RBC Capital Markets initiates Cardinal Health with a buy rating and a $276 price target, citing the company’s Nuclear Medicine business and its expected profit contribution.
EARNINGS | Aug 19, 2026, 01:15 PM UTC
L
CAH initiated Outperform at RBC Capital with $276 target
RBC Capital initiates CAH with an Outperform rating and a $276.00 price target.
EQUITY | Aug 19, 2026, 11:55 AM UTC
H
S&P 500 Falls Ahead of Inflation Report
The S&P 500 falls for the second straight session amid a decline in tech stocks
EARNINGS | Aug 12, 2026, 06:57 AM UTC
H
Dow Falls Over 50 Points Ahead of Inflation Data: Fear Index Remains in ‘Greed’ Zone
The CNN Money Fear and Greed index showed no change in the overall market sentiment, while the index remained in the “Greed” zone on Monday. U.S. stocks settled mostly lower on Monday, with the Dow Jones index falling mo
EARNINGS | Aug 11, 2026, 07:44 AM UTC
H
Cardinal Health price target raised to $275 from $255 at TD Cowen
TD Cowen raised the firm's price target on Cardinal Health to $275 from $255 and keeps a Buy rating on the shares. The firm updated its model ahead of the upcoming earnings season and they see the company guiding FY27 ad
EQUITY | Jul 09, 2026, 12:50 PM UTC
L
B of A Securities Maintains Buy on Cardinal Health, Raises Price Target to $260
B of A Securities analyst Allen Lutz maintains Cardinal Health (NYSE: CAH ) with a Buy and raises the price target from $240 to $260.
EQUITY | Jul 02, 2026, 03:00 PM UTC